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Abstract
Several studies have recently suggested that amyloid Positron Emission Tomo-
graphy (PET) data acquired immediately after the radiotracer injection provide
information related to the brain metabolism, similar to that contained in 18F-
Fluorodeoxyglucose (FDG) PET neuroimages. If corroborated, it would allow
us to acquire information about brain injury and potential brain amyloid depo-
sits in a single examination, using a dual-point protocol.
In this work we assess the equivalence between early 18F-Florbetaben (FBB)
PET and 18F-FDG PET data using multivariate approaches based on machine
learning. In addition, we propose several systems based on data fusion that take
advantage of the additional information provided by dual-point amyloid PET ex-
aminations. The proposed systems perform an initial dimensionality reduction
of the data using a partial-least-square-based algorithm and then combine early
and standard PET acquisitions using two approaches: multiple kernel learning
(intermediate fusion) or an ensemble of two Support Vector Machine classifiers
(late fusion). The proposed approaches were evaluated and compared with other
fusion techniques using data from 43 subjects with cognitive impairments. They
achieved a good trade-off between sensitivity and specificity and higher accu-
racy rates than systems based on single-modality approaches such as standard
18F-FBB PET data or 18F-FDG PET neuroimages.
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1. Introduction
According to the World Health Organization, about 70% of cases of dementia
are due to Alzheimer’s disease (AD), a neurodegenerative disease characterized
by the presence of brain amyloid plaques and neurofibrillary tangles [1, 2]. Nowa-
days, different modalities of neuroimaging data are frequently used to diagnose5
and monitor the evolution of AD. For example, Magnetic Resonance Imaging
(MRI) is commonly used to estimate the brain atrophy caused by the disease
[3, 4]. Nevertheless, the most common neuroimaging modality in AD diagno-
sis is probably 18F-Fluorodeoxyglucose (FDG) Positron Emission Tomography
(PET) [5, 6, 7], a molecular modality that allows us to visualize the glucose me-10
tabolism. In addition, AD can be detected by looking for brain amyloid deposits
using specific radiotracers such as the N-methyl-[11C]2-(4’-methylaminophenyl)-
6-hydroxybenzothiazole, commonly referred as Pittsburgh Compound B (PiB).
This radiotracer is a radioactive analog of thioflavin T, which binds to amyloid
plaques with high affinity. Since 2012 other fluoride labeled radiotracers with15
longer half-live have been successfully used with same purpose.
Recently, some studies have suggested that amyloid radiotracers can be used
along with a dual-point (or dual-phase) protocol, allowing us to obtain two
neuroimages with different information in a single examination [8, 9]. The first
one would be acquired immediately after the radiotracer injection and would20
contain information about the neuronal injury, similar to that obtained using a
18F-FDG PET examination. Indeed, most of amyloid radiotracers are lipophilic
agents, which are commonly used to assess the regional cerebral blood flow
(rCBF), thus their early acquisition could be used to estimate the regional
cerebral metabolic rate of glucose (rCMRglc), closely related to rCBF. The25
second neuroimage would be acquired according to the kinetics of the radiotracer
and would allow us to assess the potential brain amyloid deposits [10].
In this work we evaluate the equivalence between early acquisitions of amy-
loid PET and 18F-FDG PET using multivariate approaches based on machine
learning [11]. In addition, we propose several multimodal Computer-Aided Di-30
agnosis (CAD) systems in order to take advantage of the additional information
provided by amyloid PET examinations using a dual-point protocol.
2. Material and methods
2.1. Neuroimaging dataset
A dataset with neuroimaging data from 43 subjects with cognitive impair-35
ments was used for evaluation purposes. The subjects were recruited in the
Cognitive Behavioral Unit of two tertiary hospitals in Spain. At the first vi-
sit, experienced neurologists evaluated each subject by means of cognitive tests
(including medical interviews and standardized tests for neuropsychological ex-
amination of the domains of orientation, attention, memory, executive function,40
language, visual and constructive functions, and behavior) and ordered ancil-
lary neuroimaging examinations: 18F-Florbetaben (FBB) PET and 18F-FDG






Figure 1: Comparison of the three neuroimaging modalities used in this work. Axial slices
from a FDG (top), eFBB (middle) and sFBB (bottom) neuroimage are shown. The three
neuroimages correspond to the same patient, who was diagnosed with AD.
resulting in two neuroimages: i) an early acquisition (eFBB) with information
about the neuronal injury and ii) a standard acquisition (sFBB) intended to45
evaluate the brain amyloid deposits. The acquisition of eFBB data started im-
mediately after the radiotracer injection whereas sFBB data was acquired 90
minutes after the radiotracer injection. Both acquisitions lasted for 20 minutes
[10]. The 18F-FDG PET examination was conducted according to internati-
onally accepted criteria [12], resulting in one neuroimage showing the brain50
metabolism. The acquisition protocols were as follows (further details are given
in [10]):
• Center A: A General Electric Discovery STE 16 camera was used. Data
were reconstructed using a VUE Point Iterative algorithm (5 it, 35 sub)
and filtered by a standard Z-Axis filter. The following corrections were also55
applied: Scatter; CT attenuation; well counter sensitivity and activity;
delayed event subtraction and normalization.
• Center B: A Siemens Biograph 16 camera was used. Data were recon-
structed using an OS-OM algorithm (6 it, 21 sub) and filtered by a stan-
dard Z-Axis filter. The following corrections were also applied: Scatter;60
CT attenuation; Slice coincidence location with CT.
The subjects were then monitored during at least 1 year before making a
final diagnosis. At that time, two groups were defined: AD patients and subjects
with disorders other than AD. Demographics details about the two groups are
given in table 165
All participants gave their written informed consent to participate in the
study, which complied with the principles of the Helsinki Declaration and was
approved by the hospital Ethics and Investigation Committee.
2.2. Data preprocessing
After their acquisition, the PET images were spatially and intensity norma-70
lized in order to make data from different subjects comparable. Spatial norma-
lization consisted in warping the images in a standard space, ensuring that any
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Table 1: Demographic details and group distribution of subjects involved in this work. #, µ
and σ stand for the number of patients, mean and standard deviation respectively.
Sex Age
# M F µ σ range
AD 21 12 9 65.00 7.87 49–74
Non-AD 22 15 7 63.41 9.08 42–79
given voxel in different images corresponded to the same anatomical structure
(SPM8, [13])
Subsequently the intensity of each voxel was normalized by dividing them75
by a value computed as the mean intensity of the 1% of voxels with maximum
intensity. This step was carried out individually for each image and intended to
eliminate the differences due to the use of different scanners for data acquisition.
2.3. Multivariate analysis of neuroimaging data based on statistical classifica-
tion80
Statistical classification is usually considered an instance of supervised lear-
ning where a classifier, trained with N -dimensional patterns xi and their class
labels yi ∈ {0, 1, ..., L}, is able to determine the class label of a new pattern x.
Mathematically, it can be seen as a function f : RN → {0, 1, ..., L}.
In this work, we are focusing on Support Vector Machine (SVM), a family85
of classification algorithms that builds the classification function using a hyper-
plane computed to maximize the margin between the classes [14]:
g(x) = wTx + w0 = 0 (1)
where w is the weight vector, orthogonal to the decision hyperplane, and w0
is the threshold. Once the hyperplane is defined, the class of a new unknown
pattern, xi, is estimated according to which side of the hyperplane it is, i.e. as90
the sign of wTx+w0. Each pattern is composed of a set of features that defined
it. The straightforward approach to classify neuroimages consists on using the
intensity of all voxels as features [15]. This approach may lead to the so-called
small sample size problem (small number of training patterns compared to the
number of features) [16], even when using the kernel trick [17]. The small95
sample size problem can be addressed by: i) selecting the voxels in some regions
of interest and discarding the remaining ones (requires previous knowledge) or
ii) applying some feature extraction method that summarizes the information
into a reduced set of features [6].
2.4. Feature selection based on previous knowledge100
As mentioned above, the small sample size problem can be addressed by
selecting a reduced set of features, leading to a reduction of the dimensionality
of the classification problem. In neuroimaging studies, this can be done by
selecting only the voxels in regions which are known to be affected (previous
4
knowledge) by the disease under study. The following regions are often used for105
AD [18, 8, 9]: medial temporal, lateral temporal, precuneus, posterior cingulate,
anterior cingulate, frontal, occipital, striatum, thalami and cerebellum.
2.5. Feature extraction based on Partial Least Squares
Partial Least Squares (PLS) [19] is a statistical procedure to model the
relation between a dataset of predictors, X ⊂ Rn×N , and other dataset of110
responses, Y ⊂ Rn×M . It decomposes the data into the form:
X = TPT + E
Y = UQT + F
(2)
where T ⊂ Rn×p and U ⊂ Rn×p contain the p extracted score vectors, P ⊂
RN×p and Q ⊂ RM×p are the orthogonal loadings matrices, and E ⊂ Rn×N
and F ⊂ Rn×M are the matrices of residuals.
In order to extract the most relevant features from our data, we used the115
voxel intensity of the training neuroimages and their corresponding class labels
as the datasets X and Y respectively. After performing the PLS decomposition
of those matrices, the score vectors (matrix T) summarized the training data
and were used as features. The features for new patterns (not included in the
training set) were obtained by projecting them onto the X loadings [20].120
2.6. Combining multiple neuroimage modalities
Multimodal systems have been proposed to improve the performance of the
classification procedures used in CAD systems when several examinations (for
example, several neuroimages of different modality) are available. According to
where data from different sources are combined, three different schemes can be125
defined [21]:
• Early fusion. Data from different modalities are concatenated before the
classification. The pattern xi, representing the i-th subject, is defined as:































stands for the j-th feature from neuroimage k. This approach is
indeed a fusion (concatenation) of features. Therefore, it is more sensitive
to the small sample size problem, especially when different neuroimaging
modalities are combined (as in this work), and the application of dimen-130
sionality reduction methods is usually desired. These methods can be
applied independently to each neuroimage (dimensionality reduction be-
fore fusion) or to the combined feature set (dimensionality reduction after
fusion). In this work, we used the PLS-based method described above to
summarize the features of each neuroimage before the combination.135
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Table 2: Accuracy, sensitivity and specificity achieved by a SVM classifier using i) the intensity
of all voxels as feature (top), ii) a PLS approach for feature extraction (middle) or iii) the
intensity of voxels in well-known AD ROIs (bottom). These measures were computed as the
mean (± standard deviation) of 5 repetitions of a 10-fold CV loop.
Feature extraction Image modality Accuracy Sensitivity Specificity
Voxel as feature FDG 68.84 % (± 2.08 %) 54.14 % (± 0.00 %) 80.00 % (± 4.07 %)
Voxel as feature eFBB 68.37 % (± 2.08 %) 67.62 % (± 3.98 %) 69.09 % (± 3.80 %)
Voxel as feature sFBB 72.09 % (± 2.33 %) 54.29 % (± 2.61 %) 89.09 % (± 2.49 %)
PLS FDG 71.63 % (± 1.95 %) 60.00 % (± 5.43 %) 82.73 % (± 2.03 %)
PLS eFBB 70.23 % (± 4.16 %) 62.86 % (± 5.22 %) 77.27 % (± 3.21 %)
PLS sFBB 81.40 % (± 3.29 %) 79.05 % (± 2.61 %) 83.64 % (± 5.18 %)
ROIs for AD FDG 69.77 % (± 2.33 %) 57.14 % (± 0.00 %) 81.82 % (± 4.55 %)
ROIs for AD eFBB 69.30 % (± 2.55 %) 69.52 % (± 4.26 %) 69.09 % (± 2.03 %)
ROIs for AD sFBB 73.95 % (± 1.95 %) 54.29 % (± 2.61 %) 92.73 % (± 2.49 %)
• Intermediate fusion. Data from different modalities are combined du-
ring the classification [22]. This approach involves the use of the so-called
kernel trick [17] and the combination of the kernels obtained from each









where K is the number of kernels (i.e. the number of data sources); wm140
stands for the weight for kernel km; xi, xj are feature vectors for patterns




j are subset of xi, xj with the features obtained from
the data source m. More sophisticated (non-linear) functions can also be
used, however they would make the model more complicated (increasing
the computational burden) with unclear benefits.145
• Late fusion. Data from different modalities are combined after the classi-
fication. Here, there is one classifier per modality. Each of them was used
with the data from one source. Then, the different classification outputs
are combined to obtain a single prediction per subject. Different combi-
nation options can be applied and most of them are based on a measure150
of classification confidence. In addition, different weights can be applied
to the output of each single classifier. In this work, two methodologies to
combine the classification outputs were used: i) majority voting and ii)
greatest confidence, which is computed as the distance to the hyperplane.
3. Experiments and results155
First, a SVM classifier was used to separate AD and non-AD patients using
each of the neuroimaging modalities considered in this work independently. This
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Table 3: Mean accuracy (± standard deviation) obtaining by a SVM classifier when separating
AD and non-AD patients using the intensity of voxels in specific ROIs as feature.
Region FDG eFBB sFBB
Medial temporal 61.86 % (± 4.82 %) 56.74 % (± 2.08 %) 75.35 % (± 1.27 %)
Lateral temporal 77.67 % (± 1.27 %) 62.79 % (± 1.64 %) 76.28 % (± 1.95 %)
Precuneus 71.63 % (± 1.04 %) 64.65 % (± 3.03 %) 81.86 % (± 1.95 %)
Posterior cingulate 69.77 % (± 3.68 %) 63.72 % (± 2.65 %) 75.35 % (± 1.27 %)
Anterior cingulate 50.23 % (± 3.53 %) 58.60 % (± 4.16 %) 76.28 % (± 1.04 %)
Frontal 62.33 % (± 1.04 %) 63.72 % (± 2.08 %) 73.02 % (± 1.27 %)
Occipital 70.70 % (± 2.65 %) 53.49 % (± 3.68 %) 73.02 % (± 2.08 %)
Striatum 49.77 % (± 7.28 %) 62.79 % (± 2.85 %) 77.21 % (± 3.03 %)
Parietal 69.77 % (± 1.64 %) 68.37 % (± 2.08 %) 71.63 % (± 3.03 %)
Thalami 51.63 % (± 7.95 %) 64.65 % (± 3.45 %) 71.16 % (± 2.08 %)
Cerebellum 53.95 % (± 5.55 %) 52.56 % (± 1.27 %) 62.33 % (± 1.04 %)
allowed us to compare FDG and eFBB neuroimages from the perspective of a
CAD system and determined the ability of amyloid data (sFBB) to differentiate
among AD and non-AD patients without using information about the neuronal160
injury. Due to the reduced number of patients in our datasets, the classification
performance was estimated using a 10-fold cross-validation (CV) strategy. The
accuracy, sensitivity and specificity was computed as the mean of those obtained
in 5 repetitions of the CV loop. They are shown in table 2 (top).
In that initial experiment, we used the straightforward approach for features165
extraction, i.e. the intensity of all brain voxels was used as feature. As mentio-
ned above, this approach often leads to poor results due to the small sample size
problem. Thus, we repeated the classification including a PLS feature extraction
procedure that reduced the sample size, achieving higher accuracy rates. The
results are included in table 2 (middle). After the PLS decomposition, the X170
loadings (matrix P in equation 2) define the new reduced space where data is
translated, being the first columns the dimensions gathering the most of the
total covariance between the neuroimages and their labels. Thus, in order to
visualize the regions focused by the PLS-based feature extraction algorithm,
we represented the first column of the X loadings corresponding to each data175
modality in “brain form” [23]. They are shown in figure 2.
Alternatively, we calculated the classification performance when only the
voxels in some selected ROIs are used (feature selection based on previous kno-
wledge). In this case, the Automated Anatomical Labeling (AAL) atlas [24]
was used as a mask to the select specific regions mentioned in section 2.4. The180
results when the voxels in all those ROIs were used together are also included
in table 2 (bottom) and the accuracy rates achieved with the voxels of each
individual ROI are shown in table 3.
Subsequently, we tested the 3 schemes of multimodal combination (early,
intermediate and late fusion) for each pair of neuroimaging modalities. In all185
cases, a SVM classifier was used along with either all the voxels as feature
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Table 4: Classification performance measures obtained by the multimodal CAD systems im-
plemented in this work. Accuracy, sensitivity and specificity were calculated as the mean (±
standard deviation) of 5 repetitions of a 10-fold CV loop. VaF stands for voxel as feature
Fusion approach Feats. Image modalities Accuracy Sensitivity Specificity
Early fusion VaF FDG + sFBB 73.02 % (± 1.27 %) 59.05 % (± 2.61 %) 86.36 % (± 3.21 %)
Early fusion VaF eFBB + sFBB 71.16 % (± 2.08 %) 61.90 % (± 0.00 %) 80.00 % (± 4.07 %)
Early fusion PLS FDG + sFBB 81.86 % (± 1.95 %) 77.14 % (± 3.98 %) 86.36 % (± 3.21 %)
Early fusion PLS eFBB + sFBB 77.21 % (± 1.04 %) 71.43 % (± 0.00 %) 82.73 % (± 2.03 %)
Intermediate fusion VaF FDG + sFBB 85.12 % (± 3.53 %) 81.90 % (± 3.98 %) 88.18 % (± 5.18 %)
Intermediate fusion VaF eFBB + sFBB 81.86 % (± 3.03 %) 77.14 % (± 3.98 %) 86.36 % (± 3.21 %)
Intermediate fusion PLS FDG + sFBB 83.26 % (± 1.95 %) 80.95 % (± 0.00 %) 85.45 % (± 3.80 %)
Intermediate fusion PLS eFBB + sFBB 79.07 % (± 1.64 %) 72.38 % (± 2.13 %) 85.45 % (± 3.80 %)
Late fusion VaF FDG + sFBB 76.28 % (± 1.04 %) 61.90 % (± 0.00 %) 90.00 % (± 2.03 %)
Late fusion VaF eFBB + sFBB 72.09 % (± 1.64 %) 63.81 % (± 2.61 %) 80.00 % (± 2.49 %)
Late fusion PLS FDG + sFBB 85.12 % (± 2.08 %) 80.95 % (± 0.00 %) 89.09 % (± 4.07 %)
Late fusion PLS eFBB + sFBB 83.72 % (± 2.85 %) 80.00 % (± 3.98 %) 87.27 % (± 3.80 %)
Table 5: Accuracy, sensitivity and specificity achieved by the multimodal systems that combine
the three neuroimaging modalities considered in this work. VaF stands for voxel as feature
Fusion approach Feats. Accuracy Sensitivity Specificity
Early fusion VaF 71.63 % (± 1.95 %) 62.86 % (± 2.13 %) 80.00 % (± 2.49 %)
Early fusion PLS 81.40 % (± 1.64 %) 79.05 % (± 2.61 %) 83.64 % (± 2.49 %)
Intermediate fusion VaF 81.40 % (± 4.03 %) 77.14 % (± 3.98 %) 85.45 % (± 5.93 %)
Intermediate fusion PLS 81.40 % (± 2.85 %) 79.05 % (± 4.26 %) 83.64 % (± 2.49 %)
Late fusion (greatest confidence) VaF 72.56 % (± 1.04 %) 62.86 % (± 2.13 %) 81.82 % (± 0.00 %)
Late fusion (greatest confidence) PLS 83.26 % (± 2.55 %) 79.05 % (± 2.61 %) 87.27 % (± 3.80 %)
Late fusion (majority voting) VaF 75.35 % (± 2.08 %) 70.48 % (± 2.13 %) 80.00 % (± 4.07 %)
Late fusion (majority voting) PLS 80.00 % (± 1.27 %) 74.29 % (± 2.61 %) 85.45 % (± 2.03 %)
approach or the PLS-based feature extraction method. The results are shown
in table 4. As in previous experiments, the performance of each model was
estimated by means of a 10-fold CV strategy that was repeated 5 times. The
performance of multimodal systems achieving highest accuracy rates was also190
compared in terms of their Receiver Operation Curves (ROCs). The result is
shown in figure 4. These representations allow us to compute the Area Under
the Curve (AUC), which is considered a good estimator of the classification
performance [25].
Finally, we implemented a system combining all the three available modali-195
ties. The results are shown in table 5. Three fusion approaches and two feature
extraction methodologies were analyzed. In this experiment we also evaluated
the two rules mentioned in the previous section to combine the classifier outputs
in the late fusion scheme, i.e. majority voting and greatest confidence.
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4. Discussion200
The results shown in the previous section can be analyzed from two per-
spectives: i) equivalence between FDG and eFBB data and, ii) improvement
achieved by multimodal systems compared to system using a single data moda-
lity.
On the one hand, the results shown in table 2 indicate that early acquisitions205
of 18F-FBB PET can be used as surrogates of FDG data to separate AD and non-
AD patients using machine-learning-based approaches. The accuracy achieved
by a CAD system fed by FDG or eFBB neuroimages was similar, regardless
of the feature extraction method used (about 68% using all brain voxels as
feature, 69% using the voxels in some disease-specific regions as feature, and210
70-71% using a PLS-based method for feature extraction). This suggests that
the estimation of the neuronal injury provided by eFBB neuroimages is similar
to that provided by FDG neuroimages. In addition, the regions highlighted in
figure 2 for FDB data coincide, in many cases, with those highlighted for eFBB
data. Observe that, in both cases, there are big highlighted regions located in215
the parietal and occipital lobes, which are known to be affected by AD. However,
it is worth noting that when small specific regions are considered independently,
our results were not conclusive. As shown in table 3, the accuracy rate obtained
with some regions extracted from FDG data differs widely from that obtained for
the same regions from eFBB data. In our opinion, those regions, when isolated,220
do not contain information enough to separate AD and non-AD patients and
that, along with the small size of our database, led to fluctuating results. This
also explains the low accuracy rates (almost random classification) obtained for
some regions.
The idea of using a dual-point protocol for amyloid PET to obtain informa-225
tion about the neuronal injury and amyloid deposits in a single examination is
a promising idea that can bring important social and economic benefits [8]. The
results obtained in this work support the use of early acquisitions of 18F-FBB
PET as surrogates of FDG data and are in line with previous works [9, 10] that
analyzed the equivalent between these data modalities using univariate (voxel-230
wise) approaches. Specifically, they analyzed the correlation between both data
modalities at specific target regions and concluded that they could be used
indistinctly for the same purpose.
The results shown in table 2 also reveal that sFBB is an useful biomarker
to separate AD and non-AD patients. The systems using these data provided235
better accuracy rates than those using other modalities, especially when a PLS-
based dimensionality reduction is performed. This is not strange if we bear
in mind that brain amyloid deposits are one of the neurological hallmarks of
AD and they are not present in patients with other cognitive impairments. In
addition, the good performance of the PLS-based feature extraction was also240
expected, given the effectiveness of this technique on similar problems [26, 20].
This approach transforms the data into a set of latent variables, similar to the
well-known principal component analysis method, but unlike the latter, PLS
maximizes the covariance between the data and their class labels. Hence, PLS
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provides the main advantages of PCA (large reduction of the data dimensio-245
nality, improved signal-to-noise ratio, reduced model overfitting) and performs
a data transformation focused on class separation (maximizing covariance be-
tween data and labels rather than data variance). The main disadvantages of
PLS are the loss of information (any dimensionality reduction implies the eli-
mination of some of the initial data) and the increase of the complexity of the250
model (additional parameters must be optimized).
On the other hand, a dual-point protocol for amyloid PET would make more
sense if we are able to take advantage of the additional information it provides.
Accordingly, multimodal CAD systems are a useful approach to analyze these
data. From the machine learning perspective, three general schemes have been255
proposed to combine data from different sources: early, intermediate and late
fusion [22]. The former scheme, considered as the most straightforward appro-
ach, has become more relevant during last years due to the development of deep
learning methods that are able to successfully deal with the high resulting di-
mensionality [27, 28]. However, deep learning approaches require large training260
datasets to fit the large number of parameters (related to the number of layers)
they involve [29]. This is not the case of this and many other neuroimaging
studies, thus we decided not to use deep learning approaches. However, given
that our objective was to study in depth the possibility of combining the data
provided by a dual-point protocol for amyloid PET, we analyzed all the three265
fusion schemes. As shown in table 4, combining FDG or eFBB and sFBB data
by concatenating the features (early fusion) leads to mediocre results. This can
be explained because of the large dimensionality of the input space (twice as
than in the case with only a neuroimage per patient). Conversely, intermedi-
ate and late schemes provide good accuracy rates, better than those obtained270
using a single neuroimage, making these schemes interesting approaches to take
advantage of dual-point protocols.
The performance of these two schemes was also investigated in terms of
the trade-off between sensitivity and specificity (see figure 4). A well balanced
trade-off is particularly important in the development of CAD systems, where275
both false positives and false negatives should be kept as small as possible. In
addition, we reported in figure 4 the AUC of each system, which is considered
by many to be a more representative measure of classification performance than
accuracy [25].
The equivalence between FDG and eFBB could be also investigated through280
these multimodal approaches, by comparing the performance of systems using
FDG+sFBB and eFBB+sFBB data. According to our experiments, systems
using FDG+sFBB provide higher accuracy rates than those using eFBB+sFBB.
This is consistent with results reported in [30], where the authors concluded that
FDG + 11C-PiB has better classification accuracy than early 11C-PiB + 11C-PiB285
when separating AD patients and controls subjects. These differences were not
reflected in the comparison with single-modality systems (table 2), which could
indicate a larger similarity between eFBB and sFBB than between FDG and
sFBB that makes the systems combining eFBB and sFBB have less information
than those combining FDG and sFBB.290
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Finally, the CAD systems of the last experiment, intended to assess the
potential advantages of combining FDG, eFBB and sFBB data, achieved lower
accuracy rates than systems using only two data modalities. In some sense, these
results corroborate the idea that FDG and eFBB contain similar information
and that the use of both in the same system will only increase the input space,295
making the separation problem more complex and impairing the classification
performance.
All in all, our experiments indicate that: i) eFBB data could be used as
surrogates of FDG neuroimages to distinguish between AD and non-AD patients
using machine learning methods and, ii) fusion techniques based on intermediate300
or late fusion schemes are suitable approaches to take advantage of the additional
information provided by dual-point protocols for amyloid PET. Nevertheless,
this work and the confidence in its conclusions are limited by the small size of
our dataset. We addressed this issue by using a k-fold CV strategy and repeating
the CV loop (with different sample distribution) several times, however large305
datasets are always desirable. Another limitation, related with the former, is
the use of SVM for classification. During the last decade, approaches based
on deep learning have had a great growth due to the improvements achieved
in classification tasks in different fields, including medical imaging [31, 32, 33].
However, these methods require large data sets to determine the huge amount310
of parameters they use and this is clearly not the case in our study.
5. Conclusion
Several experiments were performed to assess whether dual-point 18F-FBB
PET data could be used as biomarkers to separate AD and non-AD patients
using machine learning based methods. Our experiments indicated that the315
data acquired during early phase of 18F-FBB PET (just after the radiotracer
injection) provide similar results than 18F-FDG PET neuroimages when they are
used in modern SVM-based CAD systems for AD. In order to take advantage
of the additional information provided by dual-point protocols with amyloid
PET (the data acquired during the early phase), we proposed to use a multi-320
modal system based on intermediate or late fusion schemes. According to our
experiments, these systems are able to separate AD and non-AD patients with
higher accuracy than using only standard amyloid neuroimages, which contain
information about the potential brain amyloid deposits, or data about the brain
metabolism, such as 18F-FDG PET. Nevertheless, these results should be corro-325
borated by future studies with larger datasets. In addition, as future work, we
plan to evaluate the use of modern classification systems based on deep learning
for this problem. These systems are able to perform feature extraction along
with classification (using a single neural network) and could be useful in dealing
with the high dimensionality of data resulting from the early fusion approach.330
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Figure 2: Brain map containing the first column of X loading (matrix P in equation 2)
corresponding to the PLS decomposition of FDG (top), eFBB (middle) and sFBB (bottom)
data and their labels.
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Feature extraction method











































Figure 3: Accuracy obtained in each of the 5 repetitions of the cross validation loop for the
systems using: i) neuroimage per patient (top) or ii) two neuroimage per patient (bottom).
Blue boxes and circled dots represent accuracies’ range and median respectively.
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1 - Specificity




















FDG+sFBB (late fusion) AUC=81.73
eFBB+sFBB (late fusion) AUC=80.93
FDG+sFBB (intermediate fusion) AUC=83.72
eFBB+sFBB (intermediate fusion) AUC=84.31
Figure 4: ROC curves for four multimodal systems, two combining FDG and sFBB data and
two others combining eFBB and sFBB. The area under the curve (AUC) of each system is
shown in the legend.
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